Human adrenomedullin, a novel hypotensive peptide, contains a six-memb
er ring structure similar to that found in calcitonin gene-related pep
tide and pancreatic amylin. Unlike the full-sequence peptide, human ad
renomedullin-(15-22) [hADM-(15-22)], which contains the ring structure
: increases systemic arterial pressure in the rat but not the cat. We
undertook the present study to investigate the mechanism by which hADM
-(15-22) increases systemic arterial pressure in the rat. Injection of
hADM-(15-22) in doses of 10 to 300 nmol/kg N increased systemic aaeri
al pressure in a dose-dependent manner and was threefold less potent t
han norepinephrine when doses were compared on a nanomole basis. Howev
er, the ring structures of human calcitonin gene-related peptide and h
uman amylin, human calcitonin gene-related peptide-(1-8) and human amy
lin-(1-8), respectively, had no significant effect on systemic arteria
l pressure in the rat. Presser responses to hADM-(15-22) were reduced
significandy after administration of phentolamine or reserpine. Respon
ses to hADM-(15-22) were not altered by the angiotensin type 1 blockin
g agent DuP 753 or the endothelin-A/endothelin-B receptor blocking age
nt bosentan, and responses to hADM-(15-22) and the nicotinic agonist 1
,1-dimethyl-4-phenylpiperazinium (DMPP) were reduced after bilateral a
drenalectomy. Presser responses to DMPP were reduced by hexamethonium,
whereas the nicotinic blocking agent had no effect on the presser res
ponse to hADM-(15-22). These data suggest that increases in systemic a
rterial pressure in response to hADM-(15-22) in the rat are mediated b
y the activation of a-adrenergic receptors by catecholamines released
from the adrenal medulla. The present data suggest that hADM-(15-22) r
eleases catecholamines from the adrenal medulla by a noncholinergic me
chanism.